3.2.1.123	0.0058	-	C6-7-nitro-2,1,3-benzoxadiazole-glucosylceramide	isoform EGCrP1, at pH 6.0 and 37°C	732178	
3.2.1.123	0.0384	-	C6-7-nitro-2,1,3-benzoxadiazole-glucosylceramide	isoform EGCrP2, at pH 6.0 and 37°C	732178	
3.2.1.123	0.04	-	D-erythro-sphingosine	-	680770	
3.2.1.123	0.0436	-	resorufin	isoform EGCrP2, at pH 6.0 and 37°C	732178	
3.2.1.123	0.044	-	NeuAcalpha(2-3)Galbeta(1-4)Glcbeta(1-1)ceramide	from horse erythrocyte cell surface, pH 7, 37°C	646693	
3.2.1.123	0.047	-	GalNAcbeta(1-4)Galbeta(1-4)Glcbeta(1-1)ceramide	i.e. Gg3Cer from guinea pig erythrocyte cell surface, pH 7, 37°C	646693	
3.2.1.123	0.1	-	Galbeta(1-3)GalNAcbeta(1-4)Galbeta(1-4)Glcbeta(1-1)ceramide	pH 5, 37°C, in presence of sodium taurodeoxycholate, endoglycoceramidase I	646691	
3.2.1.123	0.15	-	Galbeta(1-3)GalNAcbeta(1-4)(NeuAcalpha(2-3))Galbeta(1-4)Glcbeta(1-1)ceramide	pH 6.5, 37°C	646688	
3.2.1.123	0.21	-	Galbeta(1-3)GalNAcbeta(1-4)Galbeta(1-4)Glcbeta(1-1)ceramide	pH 5, 37°C, in presence of sodium taurodeoxycholate, endoglycoceramidase II	646691	
3.2.1.123	0.23	-	beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide	pH 6.0, 37°C	751102